EFFICACY AND PROGRESSION OF MACULAR ATROPHY AFTER SEVEN YEARS OF TREATMENT WITH RANIBIZUMAB: THE MYOPIC SEVEN-UP
PURPOSE: To assess the seven-year efficacy of intravitreal ranibizumab (IVR) in the treatment of myopic choroidal neovascularization (mCNV), and to estimate the progression of macular atrophy. MATERIAL AND METHODS: Retrospective study with cross-sectional evaluation. Medical records of high myopic p...
Autor principal: | |
---|---|
Outros Autores: | , , , , , |
Formato: | article |
Idioma: | eng |
Publicado em: |
2016
|
Assuntos: | |
Texto completo: | https://doi.org/10.48560/rspo.7532 |
País: | Portugal |
Oai: | oai:ojs.revistas.rcaap.pt:article/7532 |